Ever Source Wealth Advisors, LLC Harvard Bioscience Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,377 shares of HBIO stock, worth $550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,377
Previous 234
488.46%
Holding current value
$550
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HBIO
# of Institutions
75Shares Held
22.5MCall Options Held
101KPut Options Held
22K-
Amh Equity LTD3.51MShares$1.4 Million2.13% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.14 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.14MShares$856,4390.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$741,5560.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.5MShares$600,6030.03% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $16.7M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...